V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20028240 | 20012023 | 1.62 | 70.6 | Curative (C) | 2016-04-17 | 2016-06-22 | FEC 100 + DOCETAXEL | 2 | N | 20099434 | FEC + DOCETAXEL |
| 20028241 | 20012023 | 1.75 | 67.3 | Adjuvant (A) | 2013-07-05 | 2013-07-26 | FEC 100 + DOCETAXEL | 02 | N | 20099434 | FEC + DOCETAXEL |
| 20028242 | 20012024 | null | null | Adjuvant (A) | 2015-09-11 | 2015-09-25 | FEC + DOCETAXEL | 2 | N | 20099438 | FEC + DOCETAXEL |
| 20028243 | 20012025 | 1.7 | 78 | Adjuvant (A) | 2016-08-22 | 2016-08-22 | FEC + DOCETAXEL | N | N | 20099440 | FEC + DOCETAXEL |
| 20028244 | 20012025 | 1.7 | 76 | Adjuvant (A) | null | 2014-11-13 | FEC + DOCETAXEL | N | null | 20099440 | FEC + DOCETAXEL |
| 20028245 | 20012026 | 1.76 | null | Adjuvant (A) | 2014-01-30 | 2014-02-13 | FEC + DOCETAXEL | N | null | 20099447 | FEC + DOCETAXEL |
| 20028246 | 20012027 | 1.61 | 69 | Adjuvant (A) | 2014-06-28 | 2014-07-04 | FEC + DOCETAXEL | 02 | N | 20099449 | FEC + DOCETAXEL |
| 20028247 | 20012028 | 1.63 | null | Neo-adjuvant (N) | 2013-07-14 | 2013-07-27 | FEC + DOCETAXEL | N | N | 20099456 | FEC + DOCETAXEL |
| 20028248 | 20012028 | 1.66 | 70.6 | Adjuvant (A) | 2017-06-22 | 2017-06-23 | FEC + DOCETAXEL | 02 | N | 20099456 | FEC + DOCETAXEL |
| 20028249 | 20012028 | 1.78 | 87.3 | Adjuvant (A) | 2013-03-15 | 2013-03-22 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20099456 | FEC + DOCETAXEL |
| 20028250 | 20012029 | 1.54 | 49 | Adjuvant (A) | 2013-05-06 | 2013-05-24 | FEC + DOCETAXEL | 02 | N | 20099472 | FEC + DOCETAXEL |
| 20028251 | 20012029 | 1.59 | 77.8 | Not known (9) | 2015-11-14 | 2015-11-26 | FEC 100 + DOCETAXEL | 02 | N | 20099472 | FEC + DOCETAXEL |
| 20028252 | 20012030 | 1.67 | 69.3 | Adjuvant (A) | null | 2014-04-22 | FEC 100 + DOCETAXEL | N | N | 20099476 | FEC + DOCETAXEL |
| 20028253 | 20012030 | null | 61 | Adjuvant (A) | 2016-06-02 | 2016-07-02 | FEC + DOCETAXEL | 2 | N | 20099476 | FEC + DOCETAXEL |
| 20028254 | 20012030 | 1.64 | 82.5 | Curative (C) | 2017-09-04 | 2017-09-20 | FEC + DOCETAXEL | 2 | N | 20099476 | FEC + DOCETAXEL |
| 20028255 | 20012030 | 1.56 | 84.7 | Adjuvant (A) | 2016-11-16 | 2016-11-17 | FEC + DOCETAXEL | 02 | N | 20099476 | FEC + DOCETAXEL |
| 20028256 | 20012030 | 1.65 | 110 | Adjuvant (A) | 2016-05-26 | 2016-06-02 | FEC + DOCETAXEL | N | N | 20099476 | FEC + DOCETAXEL |
| 20028257 | 20012031 | 1.8 | 81.4 | Adjuvant (A) | 2016-10-27 | 2016-11-03 | FEC 100 + DOCETAXEL | 2 | N | 20099490 | FEC + DOCETAXEL |
| 20028258 | 20012032 | 1.64 | 76 | Adjuvant (A) | 2018-02-20 | 2018-03-02 | FEC + DOCETAXEL | N | N | 20099494 | FEC + DOCETAXEL |
| 20028259 | 20012032 | null | 59.2 | Adjuvant (A) | 2014-09-24 | 2014-09-30 | FEC + DOCETAXEL | N | N | 20099494 | FEC + DOCETAXEL |
| 20028260 | 20012032 | 1.53 | 60.6 | Adjuvant (A) | 2013-07-05 | 2013-07-21 | FEC + DOCETAXEL | 02 | N | 20099494 | FEC + DOCETAXEL |
| 20028261 | 20012032 | 1.59 | null | Adjuvant (A) | 2017-10-11 | 2017-11-02 | FEC + DOCETAXEL | N | N | 20099494 | FEC + DOCETAXEL |
| 20028262 | 20012033 | 1.6 | 108.2 | Curative (C) | 2013-06-22 | 2013-07-02 | FEC + DOCETAXEL | 02 | N | 20099508 | FEC + DOCETAXEL |
| 20028263 | 20012034 | null | null | null | 2015-06-18 | 2015-07-14 | FEC 100 + DOCETAXEL | N | N | 20099509 | FEC + DOCETAXEL |
| 20028264 | 20012034 | 1.75 | 70 | Adjuvant (A) | 2013-07-03 | 2013-07-17 | FEC + DOCETAXEL | 99 | null | 20099509 | FEC + DOCETAXEL |
| 20028265 | 20012034 | 1.68 | null | Neo-adjuvant (N) | 2016-06-19 | 2016-06-19 | FEC + DOCETAXEL | N | null | 20099509 | FEC + DOCETAXEL |
| 20028266 | 20012034 | 1.68 | 95.7 | Not known (9) | 2015-12-18 | 2015-12-18 | FEC + DOCETAXEL | 2 | N | 20099509 | FEC + DOCETAXEL |
| 20028267 | 20012035 | 1.66 | 50 | Adjuvant (A) | 2014-10-31 | 2014-11-12 | FEC + DOCETAXEL | 02 | N | 20099523 | FEC + DOCETAXEL |
| 20028268 | 20012035 | 1.74 | 87.7 | Curative (C) | 2016-08-06 | 2016-08-10 | FEC 100 + DOCETAXEL | 2 | N | 20099523 | FEC + DOCETAXEL |
| 20028269 | 20012035 | 1.61 | 70 | Adjuvant (A) | 2013-10-13 | 2013-10-13 | FEC + DOCETAXEL | 2 | N | 20099523 | FEC + DOCETAXEL |
| 20028270 | 20012036 | 1.53 | 101 | Adjuvant (A) | 2014-02-03 | 2014-02-08 | FEC 100 + DOCETAXEL | N | N | 20099534 | FEC + DOCETAXEL |
| 20028271 | 20012037 | 1.69 | 67 | Not known (9) | 2014-08-07 | 2014-08-13 | FEC 100 + DOCETAXEL | 02 | N | 20099539 | FEC + DOCETAXEL |
| 20028272 | 20072178 | null | 72.2 | Neo-adjuvant (N) | 2016-08-12 | 2016-08-25 | FEC + DOCETAXEL | N | N | 20099542 | FEC + DOCETAXEL |
| 20028273 | 20012038 | 1.66 | 80 | Adjuvant (A) | 2015-06-01 | 2015-06-03 | FEC + DOCETAXEL | 02 | N | 20099549 | FEC + DOCETAXEL |
| 20028274 | 20072179 | 1.63 | 73.1 | Curative (C) | 2013-08-05 | 2013-08-13 | FEC 100 + DOCETAXEL | 2 | N | 20099552 | FEC + DOCETAXEL |
| 20028275 | 20072179 | null | null | Adjuvant (A) | null | 2016-05-11 | FEC 100 + DOCETAXEL | null | null | 20099552 | FEC + DOCETAXEL |
| 20028276 | 20072179 | 1.51 | 94.8 | Adjuvant (A) | 2016-12-25 | 2016-12-25 | FEC + DOCETAXEL | 2 | null | 20099552 | FEC + DOCETAXEL |
| 20028277 | 20012039 | 1.63 | 81.4 | Adjuvant (A) | 2014-09-22 | 2014-09-26 | FEC 100 + DOCETAXEL | 02 | N | 20099558 | FEC + DOCETAXEL |
| 20028278 | 20012040 | 1.6 | 73.85 | Adjuvant (A) | 2014-12-03 | 2014-12-03 | FEC + DOCETAXEL | 02 | N | 20099563 | FEC + DOCETAXEL |
| 20028279 | 20012040 | 1.58 | null | null | 2014-01-27 | 2014-02-12 | FEC + DOCETAXEL | null | N | 20099563 | FEC + DOCETAXEL |
| 20028280 | 20012040 | 1.58 | 77.2 | Neo-adjuvant (N) | 2017-09-10 | 2017-09-21 | FEC + DOCETAXEL | 02 | N | 20099563 | FEC + DOCETAXEL |
| 20028281 | 20128016 | 1.62 | null | Adjuvant (A) | null | 2015-11-23 | FEC 100 + DOCETAXEL | null | null | 20099578 | FEC + DOCETAXEL |
| 20028282 | 20128016 | 1.57 | 80.7 | Adjuvant (A) | 2015-03-01 | 2015-03-22 | FEC 100 + DOCETAXEL | N | null | 20099578 | FEC + DOCETAXEL |
| 20028283 | 20128016 | 1.58 | 62.4 | Adjuvant (A) | 2015-09-19 | 2015-10-03 | FEC 100 + DOCETAXEL | 02 | N | 20099578 | FEC + DOCETAXEL |
| 20028284 | 20128016 | 1.68 | 68 | Adjuvant (A) | 2016-09-16 | 2016-09-18 | FEC + DOCETAXEL | 02 | N | 20099578 | FEC + DOCETAXEL |
| 20028285 | 20128016 | 1.66 | 69.5 | Adjuvant (A) | 2017-07-07 | 2017-08-14 | FEC 100 + DOCETAXEL | N | N | 20099578 | FEC + DOCETAXEL |
| 20028286 | 20012041 | 1.47 | 72 | Adjuvant (A) | 2015-03-04 | 2015-03-06 | FEC + DOCETAXEL | 02 | N | 20099595 | FEC + DOCETAXEL |
| 20028287 | 20012041 | null | null | Adjuvant (A) | 2018-02-09 | 2018-02-10 | FEC 100 + DOCETAXEL | N | N | 20099595 | FEC + DOCETAXEL |
| 20028288 | 20012042 | null | 73 | Adjuvant (A) | 2016-05-25 | 2016-06-01 | FEC + DOCETAXEL | 99 | null | 20099612 | FEC + DOCETAXEL |
| 20028289 | 20012043 | 1.65 | 69 | Palliative (P) | 2016-08-27 | 2016-08-30 | FEC + DOCETAXEL | N | N | 20099617 | FEC + DOCETAXEL |